Experimental ischemia–reperfusion: biases and myths—the proximal vs. distal hypoxic tubular injury debate revisited  by Heyman, Samuel N. et al.
Experimental ischemia–reperfusion: biases and
myths—the proximal vs. distal hypoxic tubular injury
debate revisited
Samuel N. Heyman1, Christian Rosenberger2 and Seymour Rosen3
1Department of Medicine, Hadassah Hospital, Mt Scopus and the Hebrew University Medical School, Jerusalem, Israel; 2Nephrology and
Medical Intensive Care, Charite´ University Clinic, Berlin, Germany and 3Department of Pathology, Beth Israel Deaconess Medical Center
and Harvard Medical School, Boston, Massachusetts, USA
Although the understanding of processes associated with
hypoxic tubular cell injury has remarkably improved,
controversies remain regarding the appropriateness of
various animal models to the human syndrome of acute
kidney injury (AKI). We herein compare available
experimental models of hypoxic acute kidney damage, which
differ both conceptually and morphologically in the
distribution of tubular cell injury. Tubular segment types
differ in their capacity to mount hypoxia-adaptive responses,
mediated by hypoxia-inducible factors (HIFs), and in cell
type–specific molecules shed into the urine, which may serve
as early biomarkers for renal damage. These differences may
be of value in the perception of the human AKI, its detection,
and prevention.
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THE PROBLEM
Over the last four decades, the human situation of acute
tubular necrosis/acute kidney injury (ATN/AKI) has been
largely interpreted in terms of a single animal model, warm
ischemia reflow, that is, a complete interruption of arterial
blood flow for varying periods of time with maintenance of
body temperature and then reflow. Many publications and
oral presentations present the findings in this experimental
model in the context of human AKI, failing to distinguish any
differences. Although the drawbacks of this model have been
underscored,1–4 much of the myth of its equivalence to
human AKI persists. A recently reviewed manuscript begins
by the statement that ‘Ischemia reperfusion injury is the
major cause of AKI and occurs frequently due to the
obligatory interruption of blood flowyleading to renal
tubular necrosis, particularly in proximal tubule cells located
in the outer medullary regionywhich are the most susceptible
to injury and cell death.’ This statement is entirely correct
regarding the nature of AKI among rodents residing in renal
research laboratories, as warm ischemia–reperfusion (WIR) is
the most extensively used animal model, used in over 43% of
AKI studies, published in Kidney International and in NDT
over the last 3 years. Nevertheless, fundamental differences
exist between WIR models and human ATN/AKI, calling for
caution in implementing insights achieved by such models
into clinical practice. Indeed, none of the many interventions
that have proven effective in this setting alone have ever
survived critical testing in the human situation.
The aim of this review is to examine WIR in the context of
both its human functional and morphological equivalence
and consequences. It will be compared with other hypoxic
AKI models, namely cold ischemia and reperfusion (CIR)
and the so-called ‘distal nephron’ models. We shall also
discuss the implications of recent advances regarding tubular
cell hypoxic stress response and biomarkers for tubular cell
injury in the understanding of these AKI animal models.
THE HUMAN HYPOXIC AKI
Data regarding the pathophysiology and morphology of
human AKI are limited. The clinical presentation is often
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subtle, detected late, well into the established phase,
associated with multiple co-predisposing factors, and with-
out a clear-cut knowledge about the presence and distribu-
tion of renal parenchymal damage. It is important to realize
that although renal tissue sampling is infrequent in this
situation, there is a relative uniformity of opinion that overt
tissue injury is limited. Nearly all pathologists recognize this
and only make a diagnosis of AKI/ATN in clinical context,
that is, ‘basically intact renal morphology, compatible with
AKI/ATN’ (Figure 1a). This dyssynchrony of structure and
function occurs in the transplant biopsy as well. On rare
occasions, however, extensive injury is found (Figure 1b),
usually after hemodynamic catastrophes, with protracted
severe renal ischemia, such as after prolonged resuscitation,
or post-partum severe hemorrhage.4 Studies by Solez et al.,5
and later by Olsen and Hansen,6 show that tubular necrosis
(as defined by cell loss; electron microscopic observations) in
ATN/AKI is, indeed, usually very focal and limited, and
seems to affect distal tubular medullary segments (medullary
thick ascending limbs (TALs) and medullary collecting ducts
(CDs)) to a larger extent than proximal tubular segments
located in the outer medulla or the cortex.6 Interestingly,
these observations are in agreement with historical autopsies
in the pre-dialysis era in patients dying with AKI. These
reports, although imperfect to large extent, illustrate a focal
and limited injury pattern, and underscore a predominantly
distal nephron injury, named at that time ‘lower nephron
nephrosis.’7
This focal tubular injury includes the loss of brush border,
and the finding of individual tubular cell loss by electron
microscopic studies.8–12 Indeed, intact tubular cells in urine
sediments of patients with ATN are present and have been
shown to be viable. The extrusion of such cells into the urine
might lead to re-apposition of the tubular epithelium, such
that the tubule appears uninjured. Recent studies show that
tubular reconstitution can be achieved by the division of
mature cells, and studies of cyclin D1 indicate that such a
regenerative pool exists in human kidneys.13 In some
situations, apoptotic changes are also detected in human
AKI, as shown in distal nephron segments in nephrotoxic
ATN.14 Distal tubular cell apoptosis in donor biopsies before
engraftment was predictive of delayed graft function.15
Kwon’s16 group has suggested that diminished nitric oxide
generation by the injured endothelium and loss of the macula
densa neuronal nitric oxide synthase may contribute to
sustained AKI after engraftment. Aberrant hemodynamic
regulation in this situation of delayed graft function might be
related to morphological changes in vascular smooth muscle
and endothelial cells.17 The situation of ‘ATN’ in the
transplant kidney is not exactly the same as native ‘ATN,’
but does provide us with analogous circumstance of
morphological/functional dissociation and tissue is readily
available to examine multiple parameters at specific time
periods of well-documented kidney failure. The inflamma-
tory component of human AKI/ATN is minimal and related
to leukocytes within the vasa recta. Immunostaining of these
cells indicated that some are hematopoietic cells18 likely
homed/transformed as a result of hypoxia, as it occurs in the
areas of myocardial infarction scars.19
In summary, renal morphology of human AKI is dynamic,
and it depends on the timing of sampling. Tubulointerstitial
changes, if noted, are usually focal, encompassing tubular cell
necrosis, as well as programmed cell death, sublethal forms of
injury, and loss of viable cells. This may be accompanied with
by regenerative changes, vascular injury, limited inflammation,
tubular dilatation, and cast formation, principally in the
established and recovery stages of ANT. Tubular injury involves
various tubular segments, chiefly at the outer medullary region.
The limited and focal nature of human ATN markedly
contrasts with a prominent decline in glomerular filtration
rate (GFR), indicating a central role for altered glomerular
hemodynamics, possibly related to a tubulo-glomerular
feedback signal. In the absence of appropriate renal
morphology and the limited clinical usefulness of timely
determination of glomerular and tubular function, the need
for new modalities identifying tubular damage and differing
AKI from pre-renal azotemia is extremely important.
FEATURES OF THE WIR MODEL
In this technically simple model, renal blood flow is
completely interrupted by clamping of the renal artery for
Figure 1 |Human hypoxic AKI: diverse morphology and
function/morphology associations. (a) Kidney biopsy of a
25-year-old patient who presented with malaise and oliguric
acute renal failure a few days after cocaine use. A near-normal
morphology (other than some brush border diminishment, mild
interstitial edema, and mononuclear infiltration) stands in sharp
contrast with a rising serum creatinine of 7.5mg/dl on the day of
biopsy. This is a paradigm of human hypoxic AKI, characterized by
normal cortical morphology obtained by biopsy (adapted with
permission from Rosen and Stillman4). (b) Autopsy of a newborn
with huge diaphragmatic hernia and cardiorespiratory failure
despite life support management, succumbing 24 h after a
Cesarean section to bradycardia followed by a complete loss of
pulse for at least 20min. Extensive proximal tubular necrosis is
noted within the cortical labyrinth, with preservation of glomeruli
and distal nephron elements. This is the morphologic and
physiopathologic equivalent of the rat warm ischemia reflow
model, with a good function/morphology correlation. As the
human outer stripe is minimal, such ischemic changes would be
manifested in the cortex. AKI, acute kidney injury.
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a determined period of time, usually at the range of
20–60min. Throughout this period, the kidney is fully anoxic
and nonfunctioning, that is, GFR and transport activity are
fully abolished. ATN gradually develops upon reperfusion, its
extent and consistency depending on the warm ischemia
period. It is initiated at the corticomedullary junction in the
outer stripe of the outer medulla, in the form of focal S3
proximal tubule (PT) damage, extending to the medullary
ray and then finally involving the proximal convoluted
tubules in the labyrinth. After 20–30min of ischemia, S3
injury is limited and varied. As ischemic time progresses,
injury becomes more consistent and confluent. After 45min
of ischemia, the outer stripe is extensively necrotic,
accompanied by a variable degree of cortical necrosis
(mainly proximal convoluted tubular segments in the
labyrinth). After 60min of ischemia, the degree of cortical
necrosis approaches infarction.20 Distal nephron injury
(TAL) may develop if the ischemic period is prolonged or
if upon reperfusion distal tubular oxygen consumption for
transport is maintained or intensified.21 Endothelial injury,
manifested by outer medullary congestion, stasis, and
hemorrhage, is accompanied by a substantial inflammatory
response with the recruitment of neutrophils.22 Renal
dysfunction parallels the extent of tubular damage, with
reduced GFR and sodium reabsorption, and all these injury
markers are diminished by an extraordinary range of
therapeutic interventions. GFR usually recovers within a
week after WIR, but tissue damage and compromised renal
microcirculation result in hypoxia-driven chronic progressive
tubulointerstitial disease.23,24 Initial tubular regeneration is
extensive, derived from native undifferentiated cellular
elements (S3) or from local stem cells (papilla) or
exogenously derived (bone marrow).
DISSIMILARITIES OF WIR WITH HUMAN HYPOXIC AKI
WIR models markedly differ from human hypoxic ATN, both
mechanistically and morphologically. Short-termed
(20–40min) total cessation of renal blood flow and transport
activity is indeed encountered during living donor renal
transplantation and in cross-clamped aortic/renal artery
procedures. Nevertheless, most cases of ‘hypoxic’ AKI in
clinical practice are characterized by compromised renal
microcirculation and oxygenation that is related to systemic
hemodynamic derangement, to sustained critical hypoxemia,
or to various nephrotoxins that exert renal dysfunction to a
large extent by compromising renal oxygenation (such as
radiocontrast agents, nonsteroidal anti-inflammatory drugs,
or amphotericin). In these settings, renal blood flow, though
diminished at certain regions, never ceases, and oxygen
consumption for residual tubular transport does persist. The
implications of this fundamental difference are related to the
variable dependency of tubular nephron segments on oxygen
(reliance on aerobic oxidative metabolism by PT, as opposed
to the capability to use anaerobic glycolysis by TALs and CDs)
and the maintenance of energy stores in the presence of
transport activity or in its absence.25 While continuous
supply of oxygen is obligatory for PT viability, TALs are
quite resistant to hypoxia, as long as energy expenditure
for transport activity is withheld.26 This nephron segment
shares with CDs a profound ambient physiological hypoxia,
and can cope to some extent with anaerobic metabolism.
However, transport activity is the major factor governing
TAL injury during oxygen deprivation,27 probably due to
high mitochondrial respiration, leading to a rapid decline
of energy stores and the formation of reactive oxygen
species. Thus, with the complete cessation of GFR and
tubular transport, induced by renal arterial clamping,
although PTs are quickly affected, nonfunctioning TALs
maintain viability.
A second major mechanistic dissimilarity with human
hypoxic AKI is renal parenchymal temperature during
ischemia, which is most often reduced throughout major
cardiovascular surgery. Cadaveric transplants are kept at 4 1C
during cold preservation, and even living-donor-transplanted
kidneys are not kept at body temperature during the surgical
procedure. Indeed, it is important to note that clamping
of the renal artery results in an acute decrease in renal
core temperature as long as the kidney is left exposed, as its
warming is circulation-mediated. Reduction of renal
temperature in these clinical scenarios is renoprotective. By
contrast, in WIR models, the clamped kidney is most often
placed back in place and is insulated, resulting in the
maintenance of core temperature, so important to the full
and consistent expression of structural damage.28 Indeed,
cold preservation with subsequent warm reperfusion (CIR)
encountered in experimental transplantation leads to a better
preservation of PTs, and a more pronounced damage to
TALs upon reperfusion. In the original studies in trans-
planted rats, 12-h cold ischemia resulted in predominant
TAL and inner medullary injury 24 h after transplantation,
resembling distal nephron AKI models (see below). As
the cold preservation time extends beyond 16 h, PT injury in
the outer stripe and the cortex became evident as well.29,30
Such findings are in agreement with personal observations
(by S.R.) that features of both cold ischemia (inner stripe and
papillary damage) and warm ischemia (outer stripe and
cortical injury) occur if the cold ischemia time is
prolonged. In a more recent report, 24-h cold ischemia
followed by a shorter period (6 h) of transplant reperfusion,
again, resulted in predominant TAL injury.31 Finally, it is
readily acknowledged that the outer stripe of the outer
medulla, the region mostly affected by WIR, although highly
developed in rodents, has limited representation in the
human kidney.
Few additional clinically relevant hypoxic AKI models,
also with predominant S3 injury, are characterized by
profound and protracted renal hypoperfusion, produced by
prolonged resuscitation,32 with suprarenal critical aortic
narrowing,33,34 or by hemorrhagic shock.35 It is conceivable
that these models closely mimic the rare hemodynamic
catastrophes in humans that end with extensive tubular
injury as illustrated in Figure 1b.
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FEATURES OF EXPERIMENTAL ‘DISTAL NEPHRON’ HYPOXIC
AKI MODELS
As just stated, the rat kidney is anatomically different from
the human kidney, but there is an extraordinary physiological
similarity across mammalian species that concentrate urine.
This ability is dependent on the counter-current system, in
which the structure of the vasa recta (promoting reduced
oxygenation by countercurrent oxygen shunting) and high
level of sodium transport (oxygen consumption) predicate
limited oxygen availability. Indeed, rats and humans may not
share exactly the same renal anatomy, but it has been clearly
shown that substantial hypoxia exists within the mammalian
renal medulla under normal physiological conditions, a price
paid for the ability to concentrate urine.36
This understanding has led to experimental ‘distal
nephron’ models of ATN/AKI, based on the concept that in
the physiologically hypoxic renal medulla, there is a delicate
balance between oxygen supply and demand that maintains
tubular cell viability. Hypoxic AKI represents disintegration
of this equilibrium, caused by altered regional oxygen supply,
enhanced oxygen demand for tubular transport, or their
combination.36 Isolated rat kidneys perfused with oxyge-
nated, red-cell-free medium (i.e., profound hypoxia in a
functioning kidney) develop outer medullary injury, princi-
pally affecting TALs in the mid-inner stripe of the outer
medulla (as in Figure 2). S3 PT segments are involved as well,
although to a lesser extent, evidently competing with TALs
for the very limited ambient oxygen supply.37 In addition to
the corticomedullary gradient of hypoxic injury, an inner
stripe damage gradient is also noted, related to the distance
from the vasa recta, where tubules in the mid-interbundle
zone, most remote from the vasa recta, are principally
affected.38 TAL injury pattern consists of mitochondrial
swelling, with subsequent nuclear pyknosis and cell mem-
brane fragmentation. Alterations of renal oxygenation and
tubular transport, easily accomplished in the isolated kidney
model, led to the recognition that TAL damage under
hypoxic conditions correlates with transport activity. A nearly
complete protection is achieved by transport inhibition,
despite a significant decline in oxygenation and cellular
energy stores,27 suggesting a role for transport-associated
mitochondrial membrane dysfunction in the development of
cell injury, possibly due to the generation of reactive oxygen
species.39,40 Tubular damage is characteristically associated
with altered sodium reabsorption. Most importantly, obser-
vations in the isolated kidney were extended to whole-animal
models of hypoxic AKI, in which medullary oxygen balance
was compromised by various combinations of insults, leading
to enhanced single-nephron GFR and tubular transport, on
one hand, and reduction of medullary blood flow, on the
other hand. These insults included the blockade of prosta-
glandin and nitric oxide production (major factors in the
maintenance of medullary oxygen balance), the administra-
tion of radiocontrast agents and vasoconstrictors, reduction
in kidney mass (with hypertrophy of remnant nephrons),
the induction of salt depletion, heart failure, diabetes,
endotoxemia, myoglobinuria, urine outflow obstruction, or
tubulo-interstitial disease.24,36,41 In all these models, a similar
pattern of predominant TAL injury is noted (Figure 2), with
comparable distribution pattern, accompanied by S3 damage
in the adjacent outer stripe. CDs are also affected, with overt
papillary necrosis noted in some models. Additional PT
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Figure 2 | Experimental distal tubular ATN in a rat hypoxic AKI model. Medullary hypoxic damage is induced by the administration of
radiocontrast medium, concomitantly with the inhibition of prostaglandin and NO synthesis.73 As compared with intact animal (as shown in
a), in (b), tubular dysfunction is shown as early as 4 h after the induction of AKI with the use of sodium magnetic resonance imaging. The
early fall in corticomedullary sodium gradient is the hallmark of evolving injury of the countercurrent urine concentration machinery. It
parallels the development of isosthenuria, an early indicator of ATN in clinical practice. (c) Focal medullary thick ascending limb (mTAL)
injury is already noted by that time, maximal in the mid-inner strip, where 4% of mTALs are affected. An injury gradient is seen, principally
affecting tubules in the mid-interbundle zone (*), most remote from the vasa recta (VR), whereas mTALs adjacent to the VR are intact. This
limited injury pattern is associated with variable renal dysfunction, with some 10–100% increments in plasma creatinine by 24 h (CD,
collecting ducts; a and b adapted with permission from Maril et al.61).
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changes are traced in specific models, such as PT vacuoliza-
tion after radiocontrast, or S1–S2 PT injury after myoglobi-
nuria.
In the most extreme models, the extent of damage that
may reach 30–50% of TALs in the mid-inner stripe of the
outer medulla correlates with renal dysfunction.42 However,
this association is lost in more moderate models, in which
TAL injury average is about 10% or less. In these settings, rare
focal tubular injury often stands in sharp contrast with a
substantial decline in GFR, associated with preserved sodium
reabsorption, conceivably reflecting a prominent role for
altered glomerular hemodynamics. It is noteworthy that, an
inverse correlation may exist between the extent of proximal
(S1,S2) and distal tubular injury in complex sequential
models. This may reflect an effect of declining GFR, caused by
PT injury, on downstream distal tubular transport activity and
damage.43 By contrast, S3 and TAL hypoxic injury usually
parallel in distal nephron models, conceivably as they both
reside in the oxygen-deprived outer stripe and medullary rays.
Regeneration and cellular replacement in focal distal
tubular damage is more likely achieved by cellular re-
apposition or division of mature cells, as opposed to the
extensive and complex process noted in WIR.
SIMILARITIES AND DISSIMILARITIES OF HYPOXIC HUMAN AKI
AND DISTAL NEPHRON MODELS
Human studies disclose physiological medullary hypoxia, as
documented noninvasively using BOLD MRI (blood–oxygen
level-dependent magnetic resonance imaging).44 Further-
more, intensified medullary hypoxia has been detected in
various settings that induce or predispose to hypoxic AKI,
such as the administration of nonsteroidal anti-inflammatory
drugs or radiocontrast agents,45,46 in diabetes47–49 or in
patients with chronic kidney disease (Manotham K. J Am Soc
Nephrol 2006; 17: 164A). Conceivably, papillary necrosis
noted in sickle cell disease, nonsteroidal anti-inflammatory
drugs, and obstructive uropathies also reflects medullary
hypoxic AKI.
AKI is most often encountered in patients with comor-
bidities that potentially predispose to renal hypoxia. Indeed,
many of the animal models detailed above are designed to
resemble such common clinical scenarios, leading to
intensified medullary hypoxia and hypoxic AKI. It is impor-
tant that, altering prostaglandin and nitric oxide synthesis
recapitulates clinical conditions characterized by such altered
systems, such as diabetes or aging.36,50
It is important that the extensive TAL injury noted in the
cell-free perfused kidney or in the most severe distal nephron
models is unlikely to occur in human ATN. The parallel to
the human situation is far better represented by the more
moderate models that have a more limited injury pattern.
HYPOXIA-ADAPTIVE RESPONSES IN AKI MODELS
Hypoxia invokes cellular hypoxia response, mediated to a
large extent by hypoxia-inducible transcription factors
(HIFs), leading to the activation of a host of genes, many
of which are cell-protective.36 HIF response is prompt and
transient, principally regulated through the degradation of
HIFa subunits by specific oxygen-sensitive prolyl hydro-
xylases. Tubular cells differ in their capacity to generate HIF.
In vivo, CDs are potent HIF activators, whereas TALs are
weak, and PT capacity to activate HIF is intermediate.51,52
This might explain the marked tolerance of CDs to hypoxia
in AKI models.
As partially illustrated in Figure 3c and f, all renal
parenchymal cells are capable to express HIF after hypoxia or
hypoxia mimetics such as HIF prolyl hydroxylase inhibitors.
In both WIR and distal nephron AKI models, HIF activation
occurs in the renal zones where tubular injury takes place: the
outer stripe of the outer medulla (Figure 3b) and the inner
stripe (Figure 3e) and inner medulla, respectively.52
Intensification of HIF response by prolyl hydroxylase
inhibition has been suggested to confer resistance to various
forms of AKI. Indeed, this approach or the administration of
the HIF-mediated erythropoietin are the only maneuvers, so
far, that were clearly shown to attenuate both PT53–56 and
TAL hypoxic injuries.57,58 In addition to possible activation
of comparable survival pathways in the two tubular cell types,
this finding may underscore the importance of HIF-mediated
protection of the renal microcirculation,57 an inherent
component of AKI shared by all models.
ASSESSMENT OF EXPERIMENTAL HYPOXIC TUBULAR
DAMAGE: METHODOLOGICAL ADVANCES
Fine morphology in semi-thin sections of perfusion-fixed
kidneys, supplemented by electron microscopy, is essential
for proper assessment of experimental tubular damage,
allowing optimal identification of tubular cell types and
detection of various forms and stages of cell injury and death.
This may be complemented by immunostaining and
molecular imaging techniques for the detection of pro-
grammed cell death, disrupted cytoskeleton, and loss of cell
polarity. These advanced methods enable the identification of
an injury pattern that is apparently limited, or obscured by
reparative processes.
Renal injury is a dynamic process and morphology at one
time period provides only a limited perspective. Timing is
therefore a crucial point, considering the remarkable
plasticity of renal morphology that relates to both cell
dropout/loss and reparative processes. By complementing
morphology with immunostaining for both HIF and the
hypoxia marker pimonidazole (which binds to tissue at pO2
below 10mmHg, as shown in Figure 3), and killing animals
at different time points, one can scan the extent and
distribution of hypoxia, hypoxia cell response and cell
damage, identifying simultaneously lethal as well as sublethal
hypoxic cell injury. Indeed, HIF upregulation in morpholo-
gically unremarkable human allografts provides us with a
marker for subtle/sublethal hypoxic injury.59
Evolving useful noninvasive modes detecting renal par-
enchymal stress include BOLD MRI, which maps intra-renal
hypoxic regions,44,45 or contrast MRI that detect altered
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perfusion and filtration.60 Sodium MRI identifies functional
derangement of medullary sodium gradient, reflecting loss of
the countercurrent system (Figure 2), heralding evolving
hypoxic distal nephron injury.61
Biomarkers are the most prominent clinically applicable
breakthrough technologies in the early detection of AKI.62
Interestingly, two most studied urinary biomarkers, kidney
ischemia molecule (KIM)-1 and neutrophil gelatinase-associated
lipocalin (NGAL), originate from PTs and TALs, respectively.
Increased NGAL and KIM-1 in the urine is indeed noted in
AKI patients, reflecting injury in both tubular segments.63–68
It is tempting to assume that recovery of urine-cell-specific
biomarkers may provide insight regarding the distribution
pattern of tubular injury during hypoxic AKI. Urinary NGAL
was found to be a most insightful marker of radiocontrast
nephropathy,69 a prototype of hypoxia-mediated nephro-
toxicity with distal tubular injury. However, urine NGAL
is also increased in experimental cisplatin toxicity, char-
acterized by S3 injury,70 suggesting that both proximal
and distal tubular injuries coexist, possibly reflecting direct
cell toxicity (S3), combined with regional hypoxic damage
(S3 and TAL).
CLINICAL IMPLICATIONS
The differentiation between proximal and distal injury is not
merely semantic, and may have profound therapeutic
implications. For instance, enhancing GFR in evolving AKI
has been adopted by most clinicians, anticipating a better
outcome. However, according to the distal nephron injury
concept, reduced GFR during AKI is an adaptive response,
designed to reduce medullary oxygen demand, restoring
medullary oxygen balance. In this perspective, increasing
GFR might intensify medullary hypoxia and distal tubular
damage. Indeed, studies designed to enhance GFR in AKI
were not effective, and were even deleterious in subsets of
patients.71 On the other hand, attenuation of tubular
transport with the use of loop diuretics, providing improve-
ment of medullary oxygenation, a reasonable strategy
according to the same concept, has not been successful as
well, and has even shown deleterious effect following
radiocontrast studies.72 A major caveat in many of these
clinical trials is that therapeutic interventions were initiated
based on rising plasma creatinine, well into the established
phase of AKI. It is anticipated that the evolving field of
urinary biomarkers will enable an early detection of AKI and
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Figure 3 |Diverse patterns of hypoxia distribution and HIF response in hypoxic AKI models. At 24 h after insult, hypoxia (illustrated
by pimonidazole adducts, PIM) is present in both WIR (45min ischemia) and a distal nephron AKI model of contrast-induced nephropathy,73
in the outer and inner stripes of the outer medulla, respectively (a and d). HIF responses also differ: minimal upregulation in the outer
stripe in WIR (b) and a much more extensive increase in the contrast-induced nephropathy in the inner stripe (e) and in the papilla
(data not shown). For comparison, the greatest stimulation of renal HIF occurs with chemical inhibition of HIF degradation (c and f),57
underscoring a potential therapeutic implication of such a strategy. HIF, hypoxia-inducible transcription factor; WIR, warm
ischemia–reperfusion.
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intervention at its initiation phase. Furthermore, simulta-
neous detection of changes of both specific distal and
proximal urinary biomarkers might help in designing
therapeutic interventions, according to the relative impor-
tance of each tubular segment in different AKI subtypes.
In conclusion, in human hypoxic AKI, focal and limited
tubular cell damage sharply contrasts with severe impairment
of renal function. Unfortunately, this phenomenon is poorly
depicted by most experimental models, eliciting extensive
injury. Therefore, the clinical relevance of such models,
although highly consistent, is limited, and their pattern of
injury distribution may be misleading. Both proximal and
distal tubular hypoxic injuries may be observed under diverse
clinical conditions, possibly with dissimilar therapeutic
implications. Evolving strategies targeting renal microcircu-
lation, hypoxia response, and urine biomarkers could form a
base for a better detection and characterization of human
hypoxic AKI. This could lead to more appropriate and
hopefully effective interventional strategies.
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